Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
Recombinant Anti-PRMT5 (Clone RAB-C136)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-CBX2 (Clone RAB-C238)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-PRDM9 (Clone RAB-C370)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-PRDM4 (Clone RAB-C367)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-CBX1 (Clone RAB-C145)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
Anti-IL-8 [WS-4], Human IgG1, kappa
| Applications | ELISA, IHC, Neutralize |
| Reactivities | Human, Rabbit |
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AA.IV7A3
| Applications | ELISA, WB |
| Reactivities | Human |
DERP2 human monoclonal antibody, clone H.AK6.A3.F4
| Applications | ELISA, WB |
| Reactivities | Human |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-Fas (Clone R-125224)
| Applications | ELISA, FC |
| Reactivities | Human |